
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 4.200 | 4.360 | 0.160 |
Shares | 95.800 | 95.800 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 15.984 | 16.673 |
Price to Book | 2.316 | 2.467 |
Price to Sales | 1.684 | 1.752 |
Price to Cash Flow | 12.273 | 11.925 |
Dividend Yield | 2.943 | 2.929 |
5 Years Earnings Growth | 8.102 | 9.375 |
Name | Net % | Category Average |
---|---|---|
Industrials | 39.940 | 33.566 |
Healthcare | 16.390 | 14.901 |
Financial Services | 14.410 | 17.882 |
Technology | 12.230 | 9.173 |
Consumer Defensive | 9.280 | 7.872 |
Consumer Cyclical | 3.980 | 5.910 |
Basic Materials | 3.760 | 6.074 |
Number of long holdings: 37
Number of short holdings: 14
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 6.40 | 421.3 | -1.03% | |
Sandvik AB | SE0000667891 | 5.52 | 186.30 | -1.90% | |
SEB A | SE0000148884 | 5.38 | 143.70 | -1.00% | |
Volvo B | SE0000115446 | 4.98 | 251.40 | -0.67% | |
Hexagon B | SE0015961909 | 4.62 | 88.76 | -1.24% | |
Kesko | FI0009000202 | 4.49 | 19.69 | +0.36% | |
DnB | NO0010161896 | 4.35 | 259.90 | -0.04% | |
Essity B | SE0009922164 | 4.34 | 285.60 | -0.63% | |
AstraZeneca | GB0009895292 | 4.29 | 10,124.0 | -1.27% | |
Beijer Ref | SE0015949748 | 4.07 | 136.85 | -0.51% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
SE0011309707 | 128.87B | -11.45 | 8.15 | 10.03 | ||
Handelsbanken Global Tema (A1 SEK) | 45.85B | -15.56 | 3.63 | 9.46 | ||
Handelsbanken Global Tema (B1 SEK) | 45.85B | -15.56 | 3.63 | - | ||
SE0010127894 | 40.4B | -6.35 | 3.10 | - | ||
Handelsbanken Multi Asset 50 A1 S | 30.55B | -4.17 | 2.85 | 4.19 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review